Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Display Technologies | | | | | | 3,288 | 3,086 | 3,851 |
Environmental Technologies | | | | | | 1,032 | 1,053 | 1,092 |
Specialty Materials | | | | | | 1,124 | 1,107 | 1,205 |
Other | | | | | | 3,946 | 3,865 | 3,567 |
Total revenues | 14,082 | 11,303 | 11,503 | 4,347 | 10,116 | 9,390 | 9,111 | 9,715 |
Revenue growth [+] | 24.6% | -1.7% | 164.6% | -57.0% | 7.7% | 3.1% | -6.2% | 24.2% |
Display Technologies | | | | | | 6.5% | -19.9% | 51.3% |
Environmental Technologies | | | | | | -2.0% | -3.6% | 18.8% |
Specialty Materials | | | | | | 1.5% | -8.1% | 3.0% |
Life Sciences | | | | | | 2.2% | -4.8% | 1.3% |
Cost of goods sold | 9,019 | 7,772 | 7,468 | 0 | 0 | 5,627 | 5,458 | 5,663 |
Gross profit | 5,063 | 3,531 | 4,035 | 4,347 | 10,116 | 3,763 | 3,653 | 4,052 |
Gross margin | 36.0% | 31.2% | 35.1% | 100.0% | 100.0% | 40.1% | 40.1% | 41.7% |
Selling, general and administrative | 1,827 | 1,747 | 1,585 | -114 | | 1,462 | 1,508 | 1,202 |
Research and development | 995 | 1,154 | 1,031 | | | 736 | 769 | 815 |
Equity in earnings | 35 | -25 | 17 | | | 284 | 299 | 266 |
Other operating expenses | 19 | -706 | -326 | 2,881 | 8,304 | 64 | 54 | -216 |
EBITDA [+] | 3,738 | 2,831 | 3,265 | | | 2,980 | 2,805 | 3,717 |
EBITDA growth | 32.0% | -13.3% | 106.6% | -12.8% | -39.2% | 6.2% | -24.5% | 24.4% |
EBITDA margin | 26.5% | 25.0% | 28.4% | 36.3% | 17.9% | 31.7% | 30.8% | 38.3% |
Depreciation | 1,352 | 1,399 | 1,390 | | | 1,131 | 1,130 | 1,167 |
EBITA | 2,386 | 1,432 | 1,875 | 1,580 | 1,812 | 1,849 | 1,675 | 2,550 |
EBITA margin | 16.9% | 12.7% | 16.3% | 36.3% | 17.9% | 19.7% | 18.4% | 26.2% |
Amortization of intangibles | 129 | 121 | 113 | | | 64 | 54 | 33 |
EBIT [+] | 2,257 | 1,311 | 1,762 | 1,580 | 1,812 | 1,785 | 1,621 | 2,517 |
EBIT growth | 72.2% | -25.6% | 11.5% | -12.8% | 1.5% | 10.1% | -35.6% | 26.8% |
EBIT margin | 16.0% | 11.6% | 15.3% | 36.3% | 17.9% | 19.0% | 17.8% | 25.9% |
Non-recurring items [+] | 110 | 827 | 439 | -114 | | 77 | | 320 |
Asset impairment | 110 | 827 | 439 | -114 | | 77 | | 71 |
Interest expense, net [+] | 289 | 261 | 200 | 191 | 155 | 127 | 119 | 97 |
Interest expense | 300 | 276 | 221 | 191 | 155 | 159 | 140 | 123 |
Interest income | 11 | 15 | 21 | | | 32 | 21 | 26 |
Other income (expense), net [+] | 539 | 400 | 93 | | | 2,111 | -16 | 1,468 |
Gain (loss) on derivative instruments | | | | | | | 80 | 1,369 |
Other | 185 | -60 | -155 | | | -117 | -96 | 99 |
Pre-tax income | 2,397 | 623 | 1,216 | 1,503 | 1,657 | 3,692 | 1,486 | 3,568 |
Income taxes | 491 | 111 | 256 | 437 | 2,154 | -3 | 147 | 1,096 |
Tax rate | 20.5% | 17.8% | 21.1% | 29.1% | 130.0% | | 9.9% | 30.7% |
Net income | 1,079 | 414 | 862 | 1,066 | -497 | 3,695 | 1,339 | 2,472 |
Net margin | 7.7% | 3.7% | 7.5% | 24.5% | -4.9% | 39.4% | 14.7% | 25.4% |
|
Basic EPS [+] | $1.30 | $0.54 | $1.11 | $1.31 | ($0.56) | $3.62 | $1.10 | $1.89 |
Growth | 139.5% | -51.0% | -15.0% | -335.3% | -115.3% | 229.8% | -42.0% | 40.3% |
Diluted EPS [+] | $1.28 | $0.54 | $0.96 | $1.13 | ($0.56) | $3.23 | $1.00 | $1.73 |
Growth | 138.4% | -44.1% | -15.4% | -304.0% | -117.2% | 224.0% | -42.4% | 29.1% |
|
Dividends per share [+] | $0.96 | $0.88 | $0.80 | $0.72 | $0.73 | $0.54 | $0.36 | $0.52 |
Growth | 9.1% | 10.0% | 11.1% | -1.0% | 34.7% | 50.0% | -30.8% | 33.3% |
|
Shares outstanding (basic) [+] | 828 | 761 | 776 | 816 | 895 | 1,020 | 1,219 | 1,305 |
Growth | 8.8% | -1.9% | -4.9% | -8.8% | -12.3% | -16.3% | -6.6% | -10.1% |
Shares outstanding (diluted) [+] | 844 | 772 | 899 | 941 | 895 | 1,144 | 1,343 | 1,427 |
Growth | 9.3% | -14.1% | -4.5% | 5.1% | -21.8% | -14.8% | -5.9% | -2.4% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|